Literature DB >> 22030837

Structural and catalytic studies of zinc complexes containing amido-oxazolinate ligands.

Ming-Tsz Chen1, Chi-Tien Chen.   

Abstract

Several zinc complexes bearing amido-oxazolinate ligands are described. Reactions of ligand precursors, HNC(2)(E)Oxa (HNC(2)(E)Oxa = HNC(2)(Me)Oxa, HNC(2)(OMe)Oxa, HNC(2)(StBu)Oxa and HNC(2)(NMe2)Oxa) or HNPh(SMe)Oxa, with half or one molar equivalent of ZnEt(2) afford bis(chelate) zinc complexes, (NC(2)(E)Oxa)(2)Zn [C(2)(E) = propyl, (1); C(2)(E) = 2-methoxyethyl, (2); C(2)(E) = 2-N,N'-dimethylethyl, (3)] or zinc ethyl complexes, (NC(2)(StBu)Oxa)ZnEt(4) and (NPh(SMe)Oxa)ZnEt(5), using tetrahydrofuran or hexane as solvents. The zinc benzyl oxide complexes, [(NC(2)(E)Oxa)Zn(μ-OBn)](2) [C(2)(E) = propyl, (6); C(2)(E) = 2-methoxyethyl, (7); C(2)(E) = 2-tert-butylthioethyl, (8)], are obtained from the reactions of ligand precursors, HNC(2)(E)Oxa, with one molar equivalent of ZnEt(OBn) (generated in situ on 1:1 ratio of ZnEt(2) and BnOH) in tetrahydrofuran. The molecular structures are reported for compounds 1, 3, 5, 6 and 7. All eight compounds were assessed as efficient catalyst precursors towards the ring-opening polymerization of L-lactide and ε-caprolactone. This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030837     DOI: 10.1039/c1dt10974j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Zinc complexes containing coumarin-derived anilido-aldimine ligands as catalysts for ring opening polymerization of L-lactide.

Authors:  Chi-Tien Chen; Min-Chian Wang; Tzu-Lun Huang
Journal:  Molecules       Date:  2015-03-24       Impact factor: 4.411

2.  Synthesis and crystal structures of tetra-meric [2-(4,4-dimethyl-2-oxazolin-2-yl)anilido]sodium and tris-[2-(4,4-dimethyl-2-oxazolin-2-yl)anilido]ytterbium(III).

Authors:  Leah Gajecki; Brendan Twamley; David J Berg
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2020-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.